Benefits of precision medicine in lung cancer: experience from a single institution.
- Published in:
- Visualized Cancer Medicine, 2022, v. 3, p. 1, doi. 10.1051/vcm/2022005
- By:
- Publication type:
- Article
Works matching IS 27404218 AND DT 2022 AND VI 3
Results: 5
1
2
CBP/p300 bromodomain: new promising epigenetic target.
- Published in:
- Visualized Cancer Medicine, 2022, v. 3, p. 1, doi. 10.1051/vcm/2022004
- By:
- Publication type:
- Article
3
MxA: a broadly acting effector of interferon-induced human innate immunity.
- Published in:
- Visualized Cancer Medicine, 2022, v. 3, p. 1, doi. 10.1051/vcm/2022002
- By:
- Publication type:
- Article
4
Another treatment option for locally advanced hepatocellular carcinoma: Interventional arterial infusion of FOLFOX chemotherapy from the FOHAIC-1 study.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
5
An increase in early cancer detection rates at a single cancer center: Experiences from Sun Yat-sen University Cancer Center.
- Published in:
- Visualized Cancer Medicine, 2022, v. 3, p. 1, doi. 10.1051/vcm/2022001
- By:
- Publication type:
- Article